| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 639977 | Null | 0.000155853121040031 | 0.41250355 |
| NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.000155853121040031 | 0.34762898 |
| NSC 673348 | 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- | 0.000155853121040031 | 0.41784953 |
| NSC 721049 | 7Z-Plakortide H | 0.000155853121040031 | 0.35490042 |
| NSC 728856 | 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride | 0.000177788864158556 | 0.40568717 |
| NSC 753221 | 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline | 0.000177788864158556 | 0.6422194 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.000184748296800008 | 0.63262204 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.000184748296800008 | 0.6045408 |
| NSC 371777 | Null | 0.000184748296800008 | 0.30169243 |
| NSC 694620 | Null | 0.000184748296800008 | -0.22701474 |